Role of glycogen synthase kinase-3α in insulin action in cultured human skeletal muscle cells

Endocrinology

Volumn 148, Issue 9, 2007, Pages 4393-4399

  Ciaraldi, Theodore P ^b   Nikoulina, Svetlana E ^b   Bandukwala, Rahil A ^b   Carter, Leslie ^b   Henry, Robert R ^a  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; GLUCOSE; GLYCOGEN SYNTHASE; GLYCOGEN SYNTHASE KINASE 3ALPHA; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; ISOENZYME; PROTEIN KINASE B;

ADULT; ARTICLE; CELL CULTURE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GLUCOSE TRANSPORT; HORMONE ACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN RESISTANCE; MALE; MODULATION; MUSCLE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE; VELOCITY;

BIOPSY; CELLS, CULTURED; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCOSE; GLYCOGEN SYNTHASE; GLYCOGEN SYNTHASE KINASE 3; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; INSULIN RESISTANCE; MUSCLE, SKELETAL; REFERENCE VALUES; TRANSFECTION;

EID: 34548098643     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-0932     Document Type: Article

References (44)

1. Embi N, Rylatt DB, Cohen P 1980 Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur J Biochem 107:519-527
2. Doble BW, Woodgett JR 2003 GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 116:1175-1186
3. Eldar-Finkelman H, Krebs EG 1997 Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action. Proc Natl Acad Sci USA 94:9660-9664
4. Hansen L, Arden KC, Rasmussen SB, Viars CS, Vestergaard H, Hansen T, Moller AM, Woodgett JR, Pedersen O 1997 Chromosomal mapping and mutational analysis of the coding region of the glycogen synthase kinase-3α and β isoforms in patients with NIDDM. Diabetologia 40:940-946
5. Eldar-Finkelman H, Schreyer S, Shinohara M, LeBoeuf R, Krebs E 1999 Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice. Diabetes 48:1662-1666
6. Nikoulina SE, Ciaraldi TP, Mudaliar S, Mohideen P, Carter L, Henry RR 2000 Potential role of glycogen synthase kinase 3 in skeletal muscle insulin resistance of type 2 diabetes. Diabetes 49:263-271
7. Dokken BB, Sloniger JA, Henriksen EJ 2005 Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle. Am J Physiol Endocrinol Metab 288:E1188-E1194
8. Hojlund K, Staehr P, Falck Hansen B, Green KA, Hardie DG, Richter EA, Beck-Nielsen H, Wojtaszewski JFP 2003 Increased phosphorylation of skeletal muscle glycogen synthase at NH2-terminal sites during physiological hyperinsulinemia in type 2 diabetes. Diabetes 52:1393-1402
9. Nikoulina SE, Ciaraldi TP, Mudaliar S, Carter L, Johnson K, Henry RR 2002 Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscle. Diabetes 51:2190-2198
10. Henriksen EJ, Kinnick TR, Teachey MK, O'Keefe MP, Ring D, Johnson KW, Harrison SD 2003 Modulation of muscle insulin resistance by selective inhibition of GSK-3 in Zucker diabetic fatty rats. Am J Physiol Endocrinol Metab 284:E892-E900
11. MacAulay K, Hajduch E, Blair AS, Coghlan MP, Smith SA, Hundal HS 2003 Use of lithium and SB-415286 to explore the role of glycogen synthase kinase-3 in the regulation of glucose transport and glycogen synthase. Eur J Biochem 270:3829-3838
12. Ring DB, Johnson KW, Henriksen EJ, Nuss JM, Goff D, Kinnick TR, Ma ST, Reeder JW, Samuels I, Slabiak T, Wagman AS, Wernette Hammond M-E, Harrison SD 2003 Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo. Diabetes 52:588-595
13. Kaidanovich-Beilin O, Eldar-Finkelman H 2006 Long-term treatment with a novel glycogen synthase kinase-3 inhibitor improves glucose homeostasis in ob/ob mice: molecular characterization in liver and muscle. J Pharmacol Exp Ther 316:17-24
14. Hoeflich KP, Luo J, Rubie EA, Tsao M-S, Jin O, Woodgett JR 2000 Requirement for glycogen synthase kinase 3-β in cell survival and NF-κB activation. Nature 406:86-90
15. Krutzfeldt J, Kausch C, Volk A, Klein HH, Rett K, Haring HU, Stumvoll M 2000 Insulin signaling and action in cultured skeletal muscle cells from lean healthy humans with high and low insulin sensitivity. Diabetes 49:992-998
16. Woodgett JR 1991 cDNA cloning and properties of GSK3. Methods Enzymol 200:564-577
17. Butler M, McKay RA, Popoff IJ, Gaarde WA, Witchell D, Murray SF, Dean WM, Bhanot S, Monia BP 2002 Specific inhibition of PTEN expression reverses hyperglycemia in diabetic mice. Diabetes 51:1028-1034
18. Henry RR, Abrams L, Nikoulina S, Ciaraldi TP 1995 Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects. Comparison using human skeletal muscle cell cultures. Diabetes 44:936-946
19. Henry RR, Ciaraldi TP, Abrams-Carter L, Mudaliar S, Park KS, Nikoulina SE 1996 Glycogen synthase activity is reduced in cultured skeletal muscle cells of non-insulin-dependent diabetes mellitus subjects. J Clin Invest 98:1231-1236
20. Blau HM, Webster C 1981 Isolation and characterization of human muscle cells. Proc Natl Acad Sci USA 78:5623-5627
21. Sarabia V, Ramlal T, Klip A 1990 Glucose uptake in human and animal muscle cells in culture. Biochem Cell Biol 68:536-542
22. Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 71:248-254
23. Burnette WN 1981 "Western blotting" electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem 112:195-203
24. Lawrence JC, Roach PJ 1997 New insights into the role and mechanism of glycogen synthase activation by insulin. Diabetes 46:541-547
25. Nikoulina SE, Ciaraldi TP, Carter L, Mudaliar S, Park KS, Henry RR 2001 impaired muscle glycogen synthase in type 2 diabetes is associated with diminished phosphatidylinositol 3-kinase activation. J Clin Endocrinol Metab 86:4307-4314
26. Woodgett JR 2003 Physiological roles of glycogen synthase kinase-3: potential as a therapeutic target for diabetes and other disorders. Curr Drug Targets Immune Endocr Metab Disord 3:281-290
27. Cheng K, Creacy S, Larner J 1983 Insulin-like effects of lithium on isolated rat adipocytes. I. Stimulation of glycogenesis and glucose transport. Mol Cell Biochem 56:177-182
28. Choi WS, Sung CK 2000 Effects of lithium and insulin on glycogen synthesis in L6 myocytes: additive effects on inactivation of glycogen synthase kinase-3. Biochim Biophys Acta 1475:225-230
29. Coghlan MP, Culbert AA, Cross DAE, Corcoran SL, Yates JW, Pearce NJ, Rausch OL, Murphy GJ, Carter PS, Roxbee Cox L, Mills D, Browen MJ, Haigh D, Ward RW, Smith DG, Murray KJ, Reith AD, Holder JC 2000 Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem Biol 7:793-803
30. Plotkin B, Kaidanovich O, Talior I, Eldar-Finkelman H 2003 Insulin mimetic action of synthetic phosphorylated peptide inhibitors of glycogen synthase kinase-3. J Pharmacol Exp Ther 305:974-980
31. Cline GW, Johnson K, Regittnig W, Perret P, Tozzo E, Xiao L, Damico C, Shulman GI 2002 Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (fa/fa) rats. Diabetes 51:2903-2910
32. Wojtazsewski JFP, Nielsen P, Kiens B, Richter EA 2001 Regulation of glycogen synthase kinase-3 in human skeletal muscle. Effects of food intake and bicycle exercise. Diabetes 50:265-269
33. Summers SA, Kao AW, Kohn AD, Backus GS, Roth RA, Pessin JE, Birnbaum MJ 1999 The role of glycogen synthase kinase 3β in insulin-stimulated glucose metabolism. J Biol Chem 274:17934-17940
34. Gaster M, Petersen I, Hojlund K, Poulsen P, Beck-Nielsen H 2002 The diabetic phenotype is conserved in myotubes established from diabetic subjects: evidence for primary defects in glucose transport and glycogen synthase activity. Diabetes 51:921-927
35. Borthwick AC, Wells AM, Rochford JJ, Hurel SJ, Turnbull DM, Yeaman SJ 1995 Inhibition of glycogen synthase kinase-3 by insulin in cultured human skeletal muscle myoblasts. Biochem Biophys Res Commun 210:738-745
36. Park KS, Ciaraldi TP, Carter L, Mudaliar S, Nikoulina SE, Webster NJG, Henry RR 2000 Induction of insulin resistance in human skeletal muscle cells by downregulation of glycogen synthase protein expression. Metabolism 49:962-968
37. Garcia-Martinez C, Marotta M, Moore-Carrasco R, Guitart M, Camps M, Busquest S, Montell E, Gomez-Foix AM 2005 Impact on fatty acid metabolism and differential localization of FATP1 and FAT/CD36 proteins delivered in cultured human muscle cells. Am J Physiol Cell Physiol 288:C1264-C1272
38. Bouzakri K, Zachrisson A, Al-Khalili L, Zhang BB, Koistinen HA, Krook A, Zierath JR 2006 siRNA-based gene silencing reveals specialized roles of IRS-1/Akt2 and IRS-2/Akt1 in glucose and lipid metabolism in human skeletal muscle. Cell Metab 4:89-96
39. Thorburn AW, B Gumbiner, F Bulacan, G Brechtel, RR Henry 1991 Multiple defects in muscle glycogen synthase activity contribute to reduced glycogen synthesis in non-insulin dependent diabetes mellitus. J Clin Invest 87:489-495
40. Chung JW, Suh KI, Joyce M, Ditzler T, Henry RR 1995 Contribution of obesity to defects of intracellular glucose metabolism in NIDDM. Diabetes Care 18: 666-673
41. Bjornholm M, Zierath JR 2005 Insulin signal transduction in human skeletal muscle: identifying the defects in type II diabetes. Biochem Soc Trans 33:354-357
42. Gual P, Le Marchand-Brustel Y, Tanti JF 2005 Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie (Paris) 87:99-109
43. Liberman Z, Eldar-Finkelman H 2005 Serine 332 phosphorylation of insulin receptor substrate-1 by glycogen synthase kinase-3 attenuates insulin signaling. J Biol Chem 280:4422-4428
44. Pearce NJ, Arch JRS, Clapham JC, Coghlan MP, Corcoran SL, Lister CA, Llano A, Moore GB, Murphy GJ, Smith SA, Taylor CM, Yates JW, Morrison AD, Harper AJ, Roxbee-Cox L, Abuin A, Wargent E, Holder JC 2004 Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3β on a muscle-specific promoter. Metabolism 53:1322-1330